Latest Health News
WHO Faces 25% Headcount Decline by June 2026 Amid Funding Crisis
The World Health Organization will reduce its staff by 25% by June 2026 due to funding shortfalls, with similar cuts at Global Fund (37% replenishment drop) and Gavi (24%). This risks disruptions in immunization, disease surveillance, and could lead to 22 million additional preventable deaths by 2030 in LMICs. Institutions like UNICEF are also cutting 25% of global staff.
FDA Vaccine Chief Resigns Next Month Amid Controversy
The head of the FDA’s vaccine center is resigning next month, as reported in KFF Health News. A survey shows declining American trust in HHS leaders compared to pandemic levels. This occurs alongside ongoing vaccine policy debates.
FDA Advisers Endorse WHO's Flu Vaccine Strain Recommendations
The FDA's VRBPAC unanimously recommended adding subclade K to fall flu shots, following WHO guidance despite US withdrawal. Final approval rests with FDA Commissioner Martin Makary. US scientists continue international flu tracking collaboration.
CDC Reports Lower Flu Vaccine Effectiveness This Season
Interim CDC analysis shows flu vaccine effectiveness at 22-34% against outpatient visits for adults and 30-41% for seniors, with hospitalization protection at 30-31%. Viral mismatch contributes to the slump from last season. Data spans September 2025 to February 2026.
South Carolina Measles Outbreak Nears 1,000 Cases, Slowing
South Carolina's major measles outbreak is slowing, with cases dropping to ~10 per week from 200 at peak in mid-January, nearing 1,000 total. The downward trend has held for weeks. Vaccination gaps fueled the surge.
Colorado Measles Outbreak Reaches Up to 10 Cases
A measles outbreak linked to two Broomfield schools has up to 10 cases, including two new confirmations and one suspected on Thursday. Public health responses are ongoing. School-related exposure drives the cluster.
Breakthrough Gene Therapies for Macular Degeneration in 2026
RGX-314 gene therapy reduces need for monthly injections by 63.8-84.7% in trials, converting eye cells into anti-VEGF factories. Prima Bionic Vision System implant restores vision in blind patients, published in NEJM 2025. Red light therapy FDA-approved; stem cell studies advance.
Middle East Conflict Disrupts Health Services, Raises Risks
Escalating hostilities drive civilian casualties, displacement, and strained health services across Middle East, including Israel-Lebanon border. Millions face risks from overcrowded shelters and disrupted aid; children hit hardest. UN warns of deepening humanitarian crisis.
ATTD 2026 Showcases T1D Advances: AI Systems and Gene Therapy
AIDANET fully closed-loop AI system improves glycemic control without boluses in trials, outperforming standard care. Vertex stem cell therapies normalize glucose in animals; human trials start this year. Gene therapy and adjuncts highlighted.
MDA Conference Highlights Neuromuscular Breakthroughs
2026 MDA conference featured gene editing, RNA therapies, biomarkers, and trial optimizations for neuromuscular diseases. 63 oral presentations and 195 speakers advanced care models. Focus on translating research to patient outcomes.
US Hearing Addresses Rural Physician Shortage via GME Expansion
House subcommittee examines rural GME to combat projected 86,000 physician shortage; AMA supports lifting Medicare caps. Physicians stay in residency communities, aiding access. Administrative holds threaten July starts.
Global Health Funding Panic Overblown, WHO Reforms Continue
Despite cuts, WHO retains $4B+ for 2026-27 core activities, 75% funded; US adds $9.4B via new strategy. Reforms strengthen functions amid geopolitical shifts. ODA trends downward but opportunities emerge.